Nutritional StatusNCT05440604
Nutrient and Immunity Status in Children Aged 3-5 Years Consuming Their Habitual Diet With or Without Fortified Milk
A study testing Fortified milk in people with Nutritional Status and Child Nutrition Sciences, run by Société des Produits Nestlé (SPN) at 1 site in Philippines.
Trial summary
This study compares the status of key micronutrients (vitamins A, C, D, E, and zinc) in young children given investigational fortified milk versus young children consuming their habitual pattern of beverage intake (milk and non-milk beverages). Read more about this study
- Who is it for?
- Ages 36 to 54 monthsHealthy volunteers can take part
- Conditions the study is for
- Nutritional Status, Child Nutrition Sciences, Toddlers
- What is being tested?
- Fortified milk
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 112 participants
- Where
- 1 sitePhilippines
- Study dates
- 23 Jun 2022to 14 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 36 to 54 months
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Having obtained his/her parent's(s') or his/her legal guardian written informed consent and signed and dated informed consent.
- Child's parent(s)/guardian is/are of legal age of consent, must understand the informed consent and other study documents, and is/are willing and able to fulfill the requirements of the study protocol
- Age 3 years old to 4 years old and 6 months at enrolment
- Healthy at birth, singleton, full-term gestational birth (37-42 completed weeks of gestation), with a birth weight of 2.5 kg to 3.9 kg
- At the time of enrolment, the participant's weight-for-age, height-for-age, weight-for-height, BMI z-score should be within -2 to +1
- At the time of enrolment, the participant is in good health (no history of underlying metabolic or chronic disease; congenital malformation; or any other condition which, in the opinion of the investigator, is likely to interfere with: the ability of the child to ingest food, the normal growth and development of the child, or the evaluation of the infant; acute illness in a minor condition which are common in childhood such as viral or bacterial infection e.g. conjunctivitis, otitis media, upper/lower respiratory tract infection, gastroenteritis, hand foot \& mouth disease at time of enrolment is permitted) as determined by physical history, physical exam and judgement by the investigator
- Child's parent(s)/guardian can be contacted directly by telephone or mobile phone throughout the study
Who cannot join
- Chronic infectious, metabolic, genetic illness, or other disease including any condition that impacts feeding, or any outcome measures
- Child exhibits any clinical signs of potential micronutrient deficiencies (e.g., hemoglobin < 100 g/L based on screening assessment, rickets based on physical exam).
- Known or suspected cows' milk protein intolerance / lactose intolerance /allergy or severe food allergies that impact diet
- Breast milk used exclusively / mixed in place of all other milk, and/or milk alternatives at 3 years of age
- Consuming supplement(s) of relevance to the study outcome relating diet to status, vitamins A, D, E and C; zinc
- Child's family who in the Investigator's judgment cannot be expected to comply with the protocol or study procedures
Trial locations and contacts
1 site in 1 country.
Philippines1 site
Las Piñas Doctors Hospital
Las Piñas, National Capital Region
About this study
This study compares the status of key micronutrients (vitamins A, C, D, E, and zinc) in young children given investigational fortified milk versus young children consuming their habitual pattern of beverage intake (milk and non-milk beverages).
Read the detailed description
Hypothesis that Vitamin A, C, D, E and zinc status of children consuming 2 servings / day of fortified milk for 16 weeks will be better than those of children consuming their habitual pattern of beverage intake (milk and non-milk beverages, juices, sugar-sweetened drinks) for the same duration. This is based on previous study findings that (i) the toddler's and preschooler's diet, in reality, are often not optimal, putting toddlers and preschool age children at risk of insufficient intakes of several nutrients, and (ii) consuming fortified milk supplemented with these nutrients might provide optimal intakes of these nutrients.
- Conditions
- Nutritional Status, Child Nutrition Sciences, Toddlers
- Being tested
- Fortified milk
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Fortified milkOther
Commercially available milk-based fortified beverage that has an updated profile of key micronutrients along with appropriate levels of protein and other macro- and micro- nutrients, in accordance with global and local nutritional recommendations
| Study group | Role | What they receive |
|---|---|---|
| Fortified milk group | Experimental | 2 daily servings of the investigational fortified milk for 16 weeks Receives: Other: Fortified milk |
| Observational group | No intervention | will be asked to consume beverages in accordance with their habitual pattern of intake |
What is being measured
The primary outcome is the main question the study is designed to answer.
change in vitamin A status
measure in serum retinol in μmol/L
Measured: 16 weeks
change in vitamin C status
measure in plasma vitamin C in mg/dL
Measured: 16 weeks
change in vitamin D status
measure in serum 25-hydroxy vitamin D (25[OH]D) in nmol/L
Measured: 16 weeks
change in vitamin E status
measure in plasma alpha-tocopherol in mg/L
Measured: 16 weeks
change in zinc status
measure in plasma zinc in μg/dl
Measured: 16 weeks
Secondary outcomes (11)
monitor growth and development
anthropometry assessment measured by weight (kg)
Measured: 16 weeks
monitor growth and development
anthropometry assessment measured by height (cm)
Measured: 16 weeks
monitor growth and development
anthropometry assessment measured by BMI (kg/m^2)
Measured: 16 weeks
assess dietary intake
using a 24-hour Dietary Recall completed by the parent / caregiver
Measured: 4 weeks, 8 weeks, 12 weeks, 16 weeks
assess habitual pattern of food and beverage intake
using a semi-quantitative food frequency questionnaire completed by the parent / caregiver
Measured: 16 weeks
assess child developmental milestones
using Laban Quotient to assess physical, social, self-help and cognitive; minimum score 1 , maximum 5; higher scores indicate more positive outcomes
Measured: 16 weeks
assess fortified milk acceptability
using Milk Intake Diary for interventional group completed by the parent / caregiver
Measured: 4 weeks, 8 weeks, 12 weeks, 16 weeks
nucleotides status assessment
measure concentration of nucleotides
Measured: 16 weeks
monitor standard adverse events (AE)
safety assessment by monitoring the AEs linked with participation in study
Measured: 16 weeks
monitor absenteeism from day care or pre-school due to illness
safety assessment by monitoring the days of absenteeism linked with participation in study
Measured: 16 weeks
monitor concomitant medication (CM) reporting
safety assessment by monitoring number of participants that took concomitant medication linked with participation in study
Measured: 16 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2022
- Study start23 Jun 2022
- Primary completion14 Dec 2022
- Study completion14 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nutritional StatusStudies of the same condition, open and under way.
- More trials run by Société des Produits Nestlé (SPN)The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 112 participants (actual)
Sponsor and investigators
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Elvira M Estorninos, MD, Principal investigator, Las Piñas Doctors Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05440604
- Sponsor's protocol ID
- 2020.01.INF
- Status last verified
- Jul 2023
- First submitted
- 27 Jun 2022
- Last updated
- 20 Jul 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Nutrient and Immunity Status in Children Aged 3-5 Years Consuming Their Habitual Diet With or Without Fortified Milk
- ClinicalTrials.gov ID
- NCT05440604
- Acronym / sponsor ID
- 2020.01.INF
- Conditions
- Nutritional Status, Child Nutrition Sciences, Toddlers
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 112 participants (actual)
- Lead sponsor
- Société des Produits Nestlé (SPN)Industry (pharma, biotech, devices)
- Study start
- 23 Jun 2022 (actual)
- Primary completion
- 14 Dec 2022 (actual)
- Study completion
- 14 Dec 2022 (actual)
- First posted
- 1 Jul 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study compares the status of key micronutrients (vitamins A, C, D, E, and zinc) in young children given investigational fortified milk versus young children consuming their habitual pattern of beverage intake (milk and non-milk beverages).
Detailed description
Hypothesis that Vitamin A, C, D, E and zinc status of children consuming 2 servings / day of fortified milk for 16 weeks will be better than those of children consuming their habitual pattern of beverage intake (milk and non-milk beverages, juices, sugar-sweetened drinks) for the same duration. This is based on previous study findings that (i) the toddler's and preschooler's diet, in reality, are often not optimal, putting toddlers and preschool age children at risk of insufficient intakes of several nutrients, and (ii) consuming fortified milk supplemented with these nutrients might provide optimal intakes of these nutrients.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Fortified milk group | Experimental | Other: Fortified milk2 daily servings of the investigational fortified milk for 16 weeks |
| Observational group | No intervention | –will be asked to consume beverages in accordance with their habitual pattern of intake |
Who may qualify
- Ages
- 36 to 54 months
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (7 listed)
- Having obtained his/her parent's(s') or his/her legal guardian written informed consent and signed and dated informed consent.
- Child's parent(s)/guardian is/are of legal age of consent, must understand the informed consent and other study documents, and is/are willing and able to fulfill the requirements of the study protocol
- Age 3 years old to 4 years old and 6 months at enrolment
- Healthy at birth, singleton, full-term gestational birth (37-42 completed weeks of gestation), with a birth weight of 2.5 kg to 3.9 kg
- At the time of enrolment, the participant's weight-for-age, height-for-age, weight-for-height, BMI z-score should be within -2 to +1
Key exclusion criteria (6 listed)
- Chronic infectious, metabolic, genetic illness, or other disease including any condition that impacts feeding, or any outcome measures
- Child exhibits any clinical signs of potential micronutrient deficiencies (e.g., hemoglobin < 100 g/L based on screening assessment, rickets based on physical exam).
- Known or suspected cows' milk protein intolerance / lactose intolerance /allergy or severe food allergies that impact diet
- Breast milk used exclusively / mixed in place of all other milk, and/or milk alternatives at 3 years of age
- Consuming supplement(s) of relevance to the study outcome relating diet to status, vitamins A, D, E and C; zinc
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Fortified milkCommercially available milk-based fortified beverage that has an updated profile of key micronutrients along with appropriate levels of protein and other macro- and micro- nutrients, in accordance with global and local nutritional recommendations | Other | Fortified milk group |
Primary outcome
change in vitamin A status
Time frame: 16 weeks
measure in serum retinol in μmol/L
change in vitamin C status
Time frame: 16 weeks
measure in plasma vitamin C in mg/dL
change in vitamin D status
Time frame: 16 weeks
measure in serum 25-hydroxy vitamin D (25[OH]D) in nmol/L
change in vitamin E status
Time frame: 16 weeks
measure in plasma alpha-tocopherol in mg/L
change in zinc status
Time frame: 16 weeks
measure in plasma zinc in μg/dl
11 secondary outcomes
monitor growth and development
Time frame: 16 weeks
monitor growth and development
Time frame: 16 weeks
monitor growth and development
Time frame: 16 weeks
assess dietary intake
Time frame: 4 weeks, 8 weeks, 12 weeks, 16 weeks
assess habitual pattern of food and beverage intake
Time frame: 16 weeks
assess child developmental milestones
Time frame: 16 weeks
assess fortified milk acceptability
Time frame: 4 weeks, 8 weeks, 12 weeks, 16 weeks
nucleotides status assessment
Time frame: 16 weeks
monitor standard adverse events (AE)
Time frame: 16 weeks
monitor absenteeism from day care or pre-school due to illness
Time frame: 16 weeks
monitor concomitant medication (CM) reporting
Time frame: 16 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jul 2023.
Related trials for Nutritional Status
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Elvira M Estorninos, MD principal investigator
Las Piñas Doctors Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Fortified milk in people with Nutritional Status and Child Nutrition Sciences, run by Société des Produits Nestlé (SPN) at 1 site in Philippines.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Philippines. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
change in vitamin A status (time frame: 16 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2023.